Expertise in
16
conditions

Zhanna D. Kobalava

6 Miklukho Maklaya Str, 
Moscow, MOW, RU 
Expertise in
16
conditions
6 Miklukho Maklaya Str, 
Moscow, MOW, RU 

Overview

Zhanna Kobalava practices practicing medicine in Moscow, Russian Federation.

Ms. Kobalava is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Hypertension, Heart Failure, Infective Endocarditis, Endocarditis, and Percutaneous Coronary Intervention (PCI).

She is actively involved in clinical research, co-authoring 35 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

6 Miklukho Maklaya Str, Moscow, MOW 117198, Russian Federation

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
Enrollment Status: Completed
Publish Date: July 03, 2024
Intervention Type: Drug
Study Drug: Ferric Carboxymaltose
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Study of Baricitinib in Patients With COVID-19 Infection
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Study of Baricitinib in Patients With COVID-19 Infection
Enrollment Status: Completed
Publish Date: July 28, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 1 Less Clinical Trial

35 Total Publications

Corrigendum to "HIV-Related Atherosclerosis: State-of-the-Art-Review" [Current Problems in Cardiology, Volume 48, Issue 9, September 2023, 101783].
Corrigendum to "HIV-Related Atherosclerosis: State-of-the-Art-Review" [Current Problems in Cardiology, Volume 48, Issue 9, September 2023, 101783].
Journal: Current problems in cardiology
Published: November 27, 2024

Frequently Asked Questions about Zhanna D. Kobalava

Is Zhanna D. Kobalava a top-rated expert for Hypertension?

MediFind is an objective health platform that identifies experts based on real-world data. Zhanna D. Kobalava is classified as an Elite expert for Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Zhanna D. Kobalava participate in research or clinical trials?

Yes. Zhanna D. Kobalava has published 35 articles and abstracts on conditions like Hypertension. You can view a list of Zhanna D. Kobalava's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Kobalava's expertise for a condition
ConditionClose
View All 12 Advanced Conditions
View All 20 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile